Effect of dietary legumes on bone-specific gene expression in ovariectomized rats
4
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
In previous studies, we found that the consumption of legumes decreased bone turnover in ovariectomized rats. The purpose of the present study is to determine whether the protective effects on bone mineral density (BMD) and the microarchitecture of a diet containing legumes are comparable. In addition, we aim to determine their protective actions in bones by studying bone specific gene expression. Forty-two Sprague-Dawley rats are being divided into six groups during the 12 week study: 1) rats that underwent sham operations (Sham), 2) ovariectomized rats fed an AIN-93M diet (OVX), 3) ovariectomized rats fed an AIN-93M diet with soybeans (OVX-S), 4) ovariectomized rats fed an AIN-93M diet with mung beans (OVX-M), 5) ovariectomized rats fed an AIN-93M diet with cowpeas (OVX-C), and 6) ovariectomized rats fed an AIN-93M diet with azuki beans (OVX-A). Consumption of legumes significantly increased BMD of the spine and femur and bone volume of the femur compared to the OVX. Serum calcium and phosphate ratio, osteocalcin, expression of osteoprotegerin (OPG), and the receptor activator of nuclear factor κB ligand (RANKL)ratio increased significantly, while urinary excretion of calcium and deoxypyridinoline and expression of TNF-α and IL-6 were significantly reduced in OVX rats fed legumes, compared to OVX rats that were not fed legumes. This study demonstrates that consumption of legumes has a beneficial effect on bone through modulation of OPG and RANKL expression in ovariectomized rats and that legume consumption can help compensate for an estrogen-deficiency by preventing bone loss induced by ovarian hormone deficiency.
Abstract
In previous studies, we found that the consumption of legumes decreased bone turnover in ovariectomized rats. The purpose of the present study is to determine whether the protective effects on bone mineral density (BMD) and the microarchitecture of a diet containing legumes are comparable. In addition, we aim to determine their protective actions in bones by studying bone specific gene expression. Forty-two Sprague-Dawley rats are being divided into six groups during the 12 week study: 1) rats that underwent sham operations (Sham), 2) ovariectomized rats fed an AIN-93M diet (OVX), 3) ovariectomized rats fed an AIN-93M diet with soybeans (OVX-S), 4) ovariectomized rats fed an AIN-93M diet with mung beans (OVX-M), 5) ovariectomized rats fed an AIN-93M diet with cowpeas (OVX-C), and 6) ovariectomized rats fed an AIN-93M diet with azuki beans (OVX-A). Consumption of legumes significantly increased BMD of the spine and femur and bone volume of the femur compared to the OVX. Serum calcium and phosphate ratio, osteocalcin, expression of osteoprotegerin (OPG), and the receptor activator of nuclear factor κB ligand (RANKL)ratio increased significantly, while urinary excretion of calcium and deoxypyridinoline and expression of TNF-α and IL-6 were significantly reduced in OVX rats fed legumes, compared to OVX rats that were not fed legumes. This study demonstrates that consumption of legumes has a beneficial effect on bone through modulation of OPG and RANKL expression in ovariectomized rats and that legume consumption can help compensate for an estrogen-deficiency by preventing bone loss induced by ovarian hormone deficiency.
참고문헌 (38)
- The fourth Korea National Health and Nutrition Examination Survey (KNHANES 4), "Ministry of Health and Welfare", Korea Centers for Disease Control and Prevention, ~ (2009)
- Gallagher JC, "The pathogenesis of osteoporosis", Bone Miner, 9, pp.215~227 (1990)
- Stĕpán JJ, "Bone loss and biochemical indices of bone remodeling in surgically induced postmenopausal women", Bone, 8, pp.279~284 (1987)
- Eghbali-Fatourechi G, "Role of RANK ligand in mediating increased bone resorption in early postmenopausal women", J Clin Invest, 111, pp.1221~1230 (2003)
- Bord S, "The effects of estrogen on osteoprotegerin, RANKL, and estrogen receptor expression in human osteoblasts", Bone, 32, pp.136~141 (2003)
- Lacey JV, "Menopausal hormone replacement therapy and risk of ovarian cancer", JAMA, 288, pp.334~341 (2002)
- Shumaker SA, "Women's Health Initiative Memory Study. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study", JAMA, 291, pp.2947~2958 (2004)
- Rozman KK, "NTP-CERHR expert panel report on the reproductive and developmental toxicity of genistein", Birth Defects Res B Dev Reprod Toxicol, 77, pp.485~638 (2006)
- Delmas PD, "Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women", N Engl J Med, 337, pp.1641~1647 (1997)
- Cosman F, "Selective estrogen receptor modulators: clinical spectrum", Endocr Rev, 20, pp.418~434 (1999)
- Setchell KD, "Soy isoflavones--benefits and risks from nature's selective estrogen receptor modulators (SERMs)", J Am Coll Nutr, 20, pp.354S~362S (2001)
- Picherit C, "Soybean isoflavones dosedependently reduce bone turnover but do not reverse established osteopenia in adult ovariectomized rats", J Nutr, 131, pp.723~728 (2001)
- Arjmandi BH, "Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis", J Nutr, 126, pp.161~167 (1996)
- 조현주, "Effects of isoflavone supplementation on the bone mineral density of growing female rats", Nutrition Research and Practice, 2(2), pp.68~73 (2008), 한국영양학회
- Zhang Y, "Genistein and a soy extract differentially affect three-dimensional bone parameters and bone-specific gene expression in ovariectomized mice", J Nutr, 139, pp.2230~2236 (2009)
- Chen KI, "Soyfoods and soybean products: from traditional use to modern applications", Appl Microbiol Biotechnol, 96, pp.9~22 (2012)
- Lee SH, "Consumption of legumes improves certain bone markers in ovariectomized rats", NUTRITION RESEARCH, 31(5), pp.397~403 (2011), PERGAMON-ELSEVIER SCIENCE LTD
- Waarsing JH, "An improved segmentation method for in vivo microCT imaging", J Bone Miner Res, 19, pp.1640~1650 (2004)
- Arjmandi BH, "Bone-sparing effect of soy protein in ovarian hormone-deficient rats is related to its isoflavone content", Am J Clin Nutr, 68, pp.1364S~1368S (1998)
- Blum SC, "Dietary soy protein maintains some indices of bone mineral density and bone formation in aged ovariectomized rats", J Nutr, 133, pp.1244~1249 (2003)
- Cai DJ, "Comparative effect of soy protein, soy isoflavones, and 17beta-estradiol on bone metabolism in adult ovariectomized rats", J Bone Miner Res, 20, pp.828~839 (2005)
- Fanti P, "The phytoestrogen genistein reduces bone loss in short-term ovariectomized rats", Osteoporos Int, 8, pp.274~281 (1998)
- Byun JS, "Effect of soybeans and sword beans on bone metabolism in a rat model of osteoporosis", Ann Nutr Metab, 56, pp.106~112 (2010)
- Wronski TJ, "Estrogen treatment prevents osteopenia and depresses bone turnover in ovariectomized rats", Endocrinology, 123, pp.681~686 (1988)
- Kalu DN, "Skeletal response of ovariectomized rats to low and high doses of 17 beta-estradiol", Bone Miner, 14, pp.175~187 (1991)
- Choi EM, "Soybean ethanol extract increases the function of osteoblastic MC3T3-E1 cells", Phytochemistry, 56, pp.733~739 (2001)
- Lee YS, "Physiological concentrations of genistein stimulate the proliferation and protect against free radical-induced oxidative damage of MC3T3-E1 osteoblast-like cells", Nutr Res, 21, pp.1287~1298 (2001)
- Chen XW, "Isoflavones regulate interleukin- 6 and osteoprotegerin synthesis during osteoblast cell differentiation via an estrogen-receptor-dependent pathway", Biochem Biophys Res Commun, 295, pp.417~422 (2002)
- Uesugi T, "Beneficial effects of soybean isoflavone supplementation on bone metabolism and serum lipids in postmenopausal Japanese women: a four-week study", J Am Coll Nutr, 21, pp.97~102 (2002)
- Scheiber MD, "Dietary inclusion of whole soy foods results in significant reductions in clinical risk factors for osteoporosis and cardiovascular disease in normal postmenopausal women", Menopause, 8, pp.384~392 (2001)
- Simonet WS, "Osteoprotegerin: a novel secreted protein involved in the regulation of bone density", Cell, 89, pp.309~319 (1997)
- Lacey DL, "Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation", Cell, 93, pp.165~176 (1998)
- Marini H, "OPG and sRANKL serum concentrations in osteopenic, postmenopausal women after 2-year genistein administration", J Bone Miner Res, 23, pp.715~720 (2008)
- Marini H, "Breast safety and efficacy of genistein aglycone for postmenopausal bone loss: a follow-up study", J Clin Endocrinol Metab, 93, pp.4787~4796 (2008)
- Pfeilschifter J, "Changes in proinflammatory cytokine activity after menopause", Endocr Rev, 23, pp.90~119 (2002)
- Ragab AA, "Cytokines synergistically induce osteoclast differentiation: support by immortalized or normal calvarial cells", Am J Physiol Cell Physiol, 283, pp.C679~C687 (2002)
- Gertz ER, "Contribution of serum inflammatory markers to changes in bone mineral content and density in postmenopausal women: a 1-year investigation", J Clin Densitom, 13, pp.277~282 (2010)
- Omi N, "Evaluation of the effect of soybean milk and soybean milk peptide on bone metabolism in the rat model with ovariectomized osteoporosis", J Nutr Sci Vitaminol (Tokyo), 40, pp.201~211 (1994)